Dr. Lilie L. Lin
Claim this profileM D Anderson Cancer Center
Studies Fallopian Tube Cancer
Studies Relapse
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Lilie L. Lin is currently running
Fluorine F 18 Fluorthanatrace PET/CT Imaging
for Breast Cancer
This phase II trial tests whether \[18F\]FluorThanatrace by positron emission tomography (PET)/computed tomography (CT) can improve imaging techniques in patients with breast cancer undergoing a standard of care biopsy or surgery. \[18F\]FluorThanatrace is a new radioactive tracer, which is a type of imaging agent that is labeled with a radioactive tag and injected into the body to help with imaging scans. PET is an established imaging technique that utilizes small amounts of radioactivity attached to very minimal amounts of tracer, in the case of this research, \[18F\]FluorThanatrace. Because some cancers take up \[18F\]FluorThanatrace it can be seen with PET. CT utilizes x-rays that traverse body from the outside. CT images provide an exact outline of organs and potential inflammatory tissue where it occurs in patient's body. \[18F\]FluorThanatrace by PET/CT may help detect the activity of a certain enzyme in the body that may be related to cancer growth in patients with breast cancer.
Recruiting1 award Phase 24 criteria
Talazoparib + Radiation
for Gynecologic Cancers
This phase I trial studies the side effects and best dose of talazoparib in combination with radiation therapy and to see how well they work in treating patients with gynecologic cancers that have come back after previous treatment (recurrent). Talazoparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving talazoparib in combination with radiation therapy may work better in treating patients with gynecologic cancers.
Recruiting1 award Phase 117 criteria
More about Lilie L. Lin
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Lilie L. Lin has experience with
- Fluorine F 18 Fluorthanatrace
- Cisplatin
- External Beam Radiation Therapy
- Nelfinavir
- Radiation Therapy
- Talazoparib
Breakdown of trials Lilie L. Lin has run
Fallopian Tube Cancer
Relapse
Breast Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lilie L. Lin specialize in?
Lilie L. Lin focuses on Fallopian Tube Cancer and Relapse. In particular, much of their work with Fallopian Tube Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Lilie L. Lin currently recruiting for clinical trials?
Yes, Lilie L. Lin is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Lilie L. Lin has studied deeply?
Yes, Lilie L. Lin has studied treatments such as Fluorine F 18 Fluorthanatrace, Cisplatin, External Beam Radiation Therapy.
What is the best way to schedule an appointment with Lilie L. Lin?
Apply for one of the trials that Lilie L. Lin is conducting.
What is the office address of Lilie L. Lin?
The office of Lilie L. Lin is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.